Wang Daniel Wei Liang, Vasconcelos Natalia Pires de, Santos Ezequiel Fajreldines Dos, Souza Fernanda Mascarenhas de, Arantes Luísa Bolaffi, Miziara Nathalia Molleis, Oliveira Bruno da Cunha de, Leite de Souza Jacqueline, Malik Ana Maria
Law School, FGV SP, São Paulo, Brazil.
Department of Sociology, University of Georgia, Athens, USA.
Health Econ Policy Law. 2025 May 27:1-19. doi: 10.1017/S1744133125000106.
While the literature has largely focused on legal challenges to public healthcare rationing decisions, claims against private insurance companies in voluntary health insurance (VHI) schemes have received less attention. This paper aims to fill this gap by analysing a representative sample of 1,547 court of appeal decisions related to treatment funding claims filed against private insurance companies in Brazil from 2018 to 2021. Courts decided 83.6% of cases in favour of patients, ordering VHI companies to fully fund the claimed treatment. Patients´ rate of success is even higher (96%) in the cases in which insurance companies denied coverage on the grounds that the claimed treatment was not listed in the benefits package mandated by regulation. Court decisions present additional challenges to setting priorities through health technology assessment and explicit packages in the VHI sector. This has broader implications for health care equality and access in Brazil.
虽然文献主要关注对公共医疗保健配给决策的法律挑战,但针对自愿医疗保险(VHI)计划中的私人保险公司的索赔却较少受到关注。本文旨在通过分析2018年至2021年期间巴西针对私人保险公司提起的与治疗资金索赔相关的1547份上诉法院判决的代表性样本,来填补这一空白。法院在83.6%的案件中做出了有利于患者的判决,命令VHI公司全额资助所要求的治疗。在保险公司以所要求的治疗未列入监管规定的福利套餐为由拒绝承保的案件中,患者的胜诉率甚至更高(96%)。法院判决给通过健康技术评估和VHI部门的明确套餐来确定优先事项带来了额外挑战。这对巴西的医疗保健平等和可及性具有更广泛的影响。